Reinhart Partners LLC. Acquires 1,127,346 Shares of Maximus, Inc. $MMS

Reinhart Partners LLC. grew its holdings in Maximus, Inc. (NYSE:MMS) by 131.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,982,415 shares of the health services provider’s stock after buying an additional 1,127,346 shares during the period. Maximus accounts for about 2.4% of Reinhart Partners LLC.’s portfolio, making the stock its 18th biggest holding. Reinhart Partners LLC.’s holdings in Maximus were worth $106,575,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in MMS. Royal Bank of Canada boosted its holdings in shares of Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after acquiring an additional 11,716 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Maximus by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after purchasing an additional 11,754 shares during the period. Jane Street Group LLC boosted its holdings in Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in shares of Maximus during the 2nd quarter worth approximately $204,000. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

MMS stock opened at $59.21 on Friday. The company has a quick ratio of 2.21, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. Maximus, Inc. has a 12 month low of $52.73 and a 12 month high of $100.00. The firm has a market cap of $3.11 billion, a P/E ratio of 8.75 and a beta of 0.59. The company’s 50-day moving average price is $58.63 and its two-hundred day moving average price is $67.46.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The firm’s quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, analysts anticipate that Maximus, Inc. will post 8.05 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a $0.33 dividend. The ex-dividend date is Friday, August 14th. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. Maximus’s dividend payout ratio (DPR) is presently 19.76%.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Key Headlines Impacting Maximus

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
• Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
• Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
• Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
• Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.